Mitchell Levine
Chairman presso IMMUNOPRECISE ANTIBODIES LTD.
Patrimonio netto: 30 400 $ in data 31/03/2024
Provenienza dei contatti di primo grado di Mitchell Levine
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
Public Company | Biotechnology | 9 | |
Smart Health Diagnostics Co
Smart Health Diagnostics Co Medical SpecialtiesHealth Technology Smart Health Diagnostics Co develops precision diagnostics. The private company is located in US.
8
| Private Company | Medical Specialties | 8 |
Enable Global Capital LLC
Enable Global Capital LLC Investment ManagersFinance Founded in 2002 by Mitchell Levine and Adam Epstein, Enable Global Capital LLC is a hedge fund manager located in San Francisco, California.
1
| Extinct | Investment Managers | 1 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Mitchell Levine tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
Quidel Corp.
Quidel Corp. Medical SpecialtiesHealth Technology Quidel Corp. engages in the development, manufacture and market of rapid diagnostic testing solutions. Its portfolio includes rapid immunoassays, cardiac immunoassays, specialized diagnostic solutions and molecular diagnostic solutions. The firm products are directly sold to end users and distributors and for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies and wellness screening centers. The company was founded in 1979 and is headquartered in San Diego, CA. | Medical Specialties | Director/Board Member | |
AFFYMETRIX, INC. | Medical Specialties | Corporate Officer/Principal | |
ORGENESIS INC. | Biotechnology | Director/Board Member | |
GUARDANT HEALTH, INC. | Medical/Nursing Services | Sales & Marketing | |
Aldevron LLC
Aldevron LLC BiotechnologyHealth Technology Aldevron LLC engages in the provision of biotechnology services. It offers plasmid DNA, antibodies, and proteins. The company was founded by Michael Chambers and John Ballantyne in 1998 and is headquartered in Fargo, ND. | Biotechnology | Corporate Officer/Principal | |
Concordia University | College/University | Corporate Officer/Principal | |
North Dakota State University | College/University | Doctorate Degree Undergraduate Degree | |
University of Kansas | College/University | Undergraduate Degree | |
University of San Francisco | College/University | Undergraduate Degree | |
University of Victoria | College/University | Doctorate Degree | |
University of Delhi | College/University | Undergraduate Degree | |
Ogeda SA
Ogeda SA Pharmaceuticals: MajorHealth Technology Ogeda SA discovers and develops small molecule drugs. It develops NK3 antagonists for the treatment of hormone-dependent pathologies in the field of Women's Health. The company was founded in 1994 and is headquartered in Gosselies, Spain. | Pharmaceuticals: Major | Director/Board Member | |
Radboud University Nijmegen | College/University | Doctorate Degree | |
Intrexon ActoBiotics NV
Intrexon ActoBiotics NV BiotechnologyHealth Technology Intrexon ActoBiotics NV manufactures biopharmaceutical products. It focuses on the development and commercialization of a new generation of biological drugs. The company represents a novel concept for oral administration of therapeutic proteins, and is designed to be safer and more effective than injectable biopharmaceuticals. Intrexon Actobioticswas founded by Mark Vaeck, Emil Pot and Bernard Coulie in June 2006 and is headquartered in Zwijnaarde, Belgium. | Biotechnology | Director/Board Member | |
Bio-Incubator Leuven
Bio-Incubator Leuven Real Estate DevelopmentFinance Bio-Incubator Leuven is a dynamic and innovative environment that provides lab space and support to R&D-intensive life sciences companies. The private company offers customizable modules that can be modified to meet the specific requirements of each client. The company is based in Leuven, Belgium. Leuven's knowledge institutes, including KU Leuven, University Hospitals Leuven, VIB, and IMEC, generate a huge outflow of knowledge that entails a myriad of innovative ideas for new and existing companies. The CEO of the Belgian company is Michaël de Blauwe. | Real Estate Development | Director/Board Member | |
PROMETHERA Biosciences SA
PROMETHERA Biosciences SA Pharmaceuticals: MajorHealth Technology PROMETHERA Biosciences SA discovers, develops and commercializes cell therapy products to treat liver diseases. It operates as a pharmaceutical company that develops treatment based on allogeneic adult stem cell technology. The firm’s technology platform is based on a newly discovered cell type, isolated from normal human adult liver tissue: Heterologous Human Adult Liver Progenitor Cells (HHALPC). The company was founded by Etienne Marc Sokal and Eric Halioua on February 12, 2009 and is headquartered in Mont-Saint-Guibert, Belgium. | Pharmaceuticals: Major | Director/Board Member | |
Fondation Francqui | Director/Board Member | ||
Life Sciences Research Partners VZW
Life Sciences Research Partners VZW Investment Trusts/Mutual FundsMiscellaneous Life Sciences Research Partners VZW functions as a foundation or endowment. The non-profit company is based in Leuven, Belgium. The Belgian company was founded by Désiré Collen. | Investment Trusts/Mutual Funds | Director/Board Member | |
Pinnacle Investments NV | Director/Board Member | ||
Immo David NV
Immo David NV Real Estate DevelopmentFinance Immo David NV engages in the provision real estate rental, sale and purchase services. The company was founded on January 5, 2005 and is headquartered in Asse, Belgium. | Real Estate Development | Director/Board Member | |
Creabuild NV
Creabuild NV Miscellaneous Commercial ServicesCommercial Services Creabuild NV provides consulting services. The private company is based in Zaventem, Belgium. The Belgian company was founded in 2005. The CEO is Stéphane Vandervelde. | Miscellaneous Commercial Services | Director/Board Member | |
Q-Biologicals NV
Q-Biologicals NV BiotechnologyHealth Technology Q-Biologicals NV operates as a bio pharma contract development and manufacturing organization. It provides process development and bio manufacturing services to customers in the biopharmaceutical industry. The company was founded in 2011 and is headquartered in Ghent, Belgium. | Biotechnology | Director/Board Member | |
University of California | College/University | Masters Business Admin | |
iTeos Therapeutics SA
iTeos Therapeutics SA Pharmaceuticals: MajorHealth Technology iTeos Therapeutics SA engages in the discovery of immunomodulators for cancer therapy. It operates as a biotechnology company which focuses on targeting metabolism of the tumor microenvironment through development of small-molecule immunomodulators for cancer treatment. The firm develops small molecules designed to target the tumor microenvironment by inhibiting cancer-induced immune suppression. Targeting such resistance mechanisms will enhance the clinical efficacy of both standards of care treatments as well as the newer immunomodulatory therapies based on the blockade of immune checkpoints. The company was founded in 2011 by Michel Detheux and Benoit Van den Eynde and is headquartered in Gosselies, Belgium. | Pharmaceuticals: Major | Director/Board Member | |
ONCOCYTE CORPORATION | Biotechnology | Corporate Officer/Principal | |
MaSTherCell SA
MaSTherCell SA BiotechnologyHealth Technology MaSTherCell SA engages in providing cell therapy manufacturing services. The company was founded in 2011 and is headquartered in Charleroi, Belgium. | Biotechnology | Director/Board Member | |
Pienter-Jan BV
Pienter-Jan BV Miscellaneous Commercial ServicesCommercial Services Pienter-Jan BV is a Belgian company that provides business and management consulting services. The private company is based in Brasschaat, Belgium. The CEO of the company is Ann Dendoncker. | Miscellaneous Commercial Services | Director/Board Member | |
Cellmax, Inc.
Cellmax, Inc. BiotechnologyHealth Technology Cellmax, Inc. provides research and clinical testing services. It develops non-invasive, accurate blood tests for early detection of cancer. The company was founded by Atul Sharan and Ying-Chih Chang in 2013 and is headquartered in Sunnyvale, CA. | Biotechnology | Corporate Officer/Principal | |
Bioxodes SA
Bioxodes SA Pharmaceuticals: MajorHealth Technology Bioxodes SA develops pharmaceutical products. Its programme Ir-CPI, is the first in a novel class of antithrombotics, and is developed for the prevention of thrombosis in a range of applications including cardiopulmonary bypass grafting and percutaneous coronary intervention. The company was founded by Edmond Godfroid and Michel Guyaux on April 20, 2010 and is headquartered in Marche-en-Famenne, Belgium. | Pharmaceuticals: Major | Director/Board Member | |
Fund+
Fund+ Investment ManagersFinance Fund+ is an independent Venture Capital firm founded in 2015. The firm is headquartered in Leuven, Belgium. | Investment Managers | Private Equity Investor | |
INVENTIVA | Biotechnology | Director/Board Member | |
Immunoprecise Antibodies (Europe) BV
Immunoprecise Antibodies (Europe) BV Pharmaceuticals: MajorHealth Technology Immunoprecise Antibodies (Europe) BV operates as a pharmaceutical company that specializes in antibiotics. Its services include antigen selection, antibody generation, antibody optimization, antibody production, antibody processing and assay development. The company was founded in 2004 and is headquartered in Oss, the Netherlands. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
CoBioRes NV | Director/Board Member | ||
EyeD Pharma SA
EyeD Pharma SA Medical SpecialtiesHealth Technology EyeD Pharma SA manufactures and supplies ophthalmology surgical products. Its products include R&D, instrumentation and phaco accessories. The company was founded by Jean-Marie Rakic and Jean-Michel Foidart and is headquartered in Liege, Belgium. | Medical Specialties | Director/Board Member | |
Concordia College Global Vaccine Institute | College/University | Founder | |
HYLORIS PHARMACEUTICALS SA | Pharmaceuticals: Major | Director/Board Member | |
Patcobel NV
Patcobel NV Real Estate DevelopmentFinance Patcobel NV provides real estate services. The private company is based in Kortrijk, Belgium. The CEOs are Cindy van Loock and Patrick Lippens. The Belgian company was founded in 1989. | Real Estate Development | Director/Board Member | |
Roche Sequencing Solutions, Inc.
Roche Sequencing Solutions, Inc. Medical/Nursing ServicesHealth Services Roche Sequencing Solutions, Inc. engages in providing personalized healthcare by creating diagnostics and treatments tailored to individual genetic and disease profiles. The firm's solutions include NGS Oncology Assays, sample collection, nucleic acid extraction and library preparation. The company is headquartered in Pleasanton, CA. | Medical/Nursing Services | Director/Board Member | |
SmartHealth Diagnostics, Inc.
SmartHealth Diagnostics, Inc. Medical/Nursing ServicesHealth Services SmartHealth Diagnostics, Inc. operates diagnostic centers. The company is based in Irvine, CA and has subsidiaries in United States. The CEO of the company is Matthew Nunez. | Medical/Nursing Services | Director/Board Member Director/Board Member | |
Muse Microscopy, Inc.
Muse Microscopy, Inc. Medical/Nursing ServicesHealth Services Part of SmartHealth Diagnostics, Inc., Muse Microscopy, Inc. provides digital microscope and imaging based diagnostics. The private company is based in Irvine, CA. Muse Microscopy was acquired by SmartHealth Diagnostics, Inc. on November 09, 2021. | Medical/Nursing Services | Chairman President | |
Cellaïon SA
Cellaïon SA BiotechnologyHealth Technology Cellaïon SA is a biotech company located in Mont Saint Guibert, Belgium. Cellaïon aims to restore a favorable environment to reboost the regenerative process of the liver and ensure a second life to the native liver instead of losing it. The Belgian company has a strong IP base issued from their own research and academic research at UCLouvain, developed with the objective to generate new products. Cellaïon's treatment covers the wide spectrum of liver diseases, from the highly life-threatening acute-on-chronic liver-failure (ACLF) and acute alcoholic hepatitis, to intermediate severity acute decompensation of cirrhosis (AD) and progressive chronic liver diseases caused by non-alcoholic steatohepatitis (NASH). The company has built up a series of R&D and collaborative partnerships with both industrial and academic partners, allowing Cellaïon to broaden and accelerate its clinical development. The company was founded by Etienne Marc Sokal, who has been the CEO since incorporation. | Biotechnology | Director/Board Member | |
Louis Jeantet Foundation | Director/Board Member |
Statistiche
Distribuzione geografica
Belgio | 23 |
Stati Uniti | 22 |
Canada | 3 |
Paesi Bassi | 3 |
India | 2 |
Settori
Health Technology | 21 |
Consumer Services | 10 |
Finance | 9 |
Health Services | 5 |
Commercial Services | 3 |
Posizioni
Director/Board Member | 66 |
Corporate Officer/Principal | 22 |
Undergraduate Degree | 8 |
President | 8 |
Independent Dir/Board Member | 7 |
Contatti più connessi
Insiders | |
---|---|
Chris Buyse | 39 |
Douglas Harrington | 22 |
Gus Blass | 20 |
Padma Sundar | 8 |
Brendan O'Neil | 7 |
Jennifer Bath | 6 |
Ilse Roodink | 3 |
Larry Dentice | 2 |
Dirk Witters | 2 |
Barry Duplantis | 2 |
Susie Lu | 2 |
Kari Graber | 2 |
Frederick Chabot | 1 |
Barry Springer | 1 |
Matthew Nuñez | 1 |
- Borsa valori
- Insiders
- Mitchell Levine
- Connessioni Società